跳至主要内容
临床试验/JPRN-UMIN000009012
JPRN-UMIN000009012已完成未知

Influence of regulatory T cells on resistance mechanisms to epidermal growth factor receptor inhibitors: an observational study - INTREPID-i (INfluence of Treg on Resistance mechanism to EPIDermal growth factor receptor inhibitors) study

Oita University Faculty Of Medicine Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients had a medical history of treatment with gefitinib, erlotinib,afatinib, cetuximab, or panitumumab. 2.The patient has received systemic chemotherapy within 21 days or therapeutic radiation therapy within 14 days prior to the first dose of study therapy. Palliative radiation is permitted. 3.Patients have severe complications, as active infection and poorly controlled diabetes. 4.Patients has allergy, which is expected to interrupt the study. 5.Pregnant women 6.Multiple primary cancer. 7.Patients regularly use corticosteroids and immunosuppressive drugs. Inhalation and topical use are permitted.

研究者

发起方
Oita University Faculty Of Medicine Graduate School of Medicine

相似试验